Are you Dr. Ly?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 6 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
780 Welch Rd
Mail Code 5776
Palo Alto, CA 94304Phone+1 650-215-0732- Is this information wrong?
Summary
- Dr. Trang Ly, MD is a pediatric endocrinologist in Palo Alto, California. She is currently licensed to practice medicine in Tennessee, Michigan, and South Carolina.
Certifications & Licensure
MI State Medical License 2017 - 2021
TN State Medical License 2017 - 2020
SC State Medical License 2016 - 2019
TX State Medical License 2012 - 2019
GA State Medical License 2016 - 2019
LA State Medical License 2014 - 2019
NC State Medical License 2016 - 2019- Join now to see all
Clinical Trials
- Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes Start of enrollment: 2016 Apr 18
Publications & Presentations
PubMed
- 38 citationsHybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.Stacey M. Anderson, Bruce A. Buckingham, Marc D. Breton, Jessica Robic, Charlotte L. Barnett
Diabetes Technology & Therapeutics. 2019-05-22 - 31 citationsPerformance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 DiabetesBruce A. Buckingham, Mark P. Christiansen, Gregory P. Forlenza, R. Paul Wadwa, Thomas A. Peyser
Diabetes Technology & Therapeutics. 2018-09-01 - 148 citationsHome use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.El-Khatib Firas H, Courtney A. Balliro, Mallory A. Hillard, Kendra L. Magyar, Laya Ekhlaspour
Lancet. 2017-01-28
Press Mentions
- FDA Clears Insulet Omnipod 5 for Children Two Years and OlderAugust 22nd, 2022
- Insulet Reports Positive Data from Omnipod 5 Insulin Delivery System TrialJune 6th, 2022
- Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes over 12 Months of Use in Children Aged 2 Through 5.9 YearsJune 3rd, 2022
- Join now to see all
